About: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1977

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 1977 (uk) im Juli 1977 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 July 1977 (en) artículu científicu espublizáu en xunetu de 1977 (ast)
publication date	wds:Q66881435-46AEBE11-477C-456E-905F-CD47B144EB4D
publication date	1977-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q66881435-F40D47D4-0658-4447-9176-857B46AD5EAA
language of work or name	English
cites work	wds:Q66881435-A74A595F-8992-4E75-917F-B578A75F142B wds:Q66881435-BC13A01A-4433-43FD-9C43-AC1E9517F110 wds:Q66881435-E2A2427C-0B33-4DF2-BD7D-18A5D88C898C wds:Q66881435-ECFFABB4-A40F-41F8-85A1-C136BCD7C980
cites work	Tuberculosis studies in Muscogee County, Georgia. Twenty-year evaluation of a community trial of BCG vaccination Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control Benefits and costs of the schools' BCG vaccination programme Evaluation of BCG vaccination among Puerto Rican children
author name string	wds:Q66881435-422BE46A-476A-4849-8740-13FBECB82FCB wds:Q66881435-B95D9D50-0445-49F2-9DBD-F491BCAD5F86
author name string	I Sutherland P D Hart
rdfs:label	BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (en) BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (nl)
skos:prefLabel	BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (en) BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (nl)
name	BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (en) BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (nl)
title	wds:Q66881435-D1F476E0-B13F-4C43-85CA-5E8A947179F1
title	BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life (en)
page(s)	wds:Q66881435-4067BC27-7447-4027-92D8-C22CDCEB9541
page(s)	293-295
instance of	wds:Q66881435-C4EA3751-72D9-4AB0-8499-1B5ED2D8050E
instance of	scholarly article
main subject	wds:Q66881435-6853B215-2585-43B3-810F-BC6C2171E3C2
main subject	tuberculosis
PubMed ID	wds:Q66881435-4686F081-39CE-419B-83CA-B9457E561F77
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/326347
PubMed ID	326347
published in	wds:Q66881435-3141EDA0-47AF-4B52-97D5-559A4721CDFF
published in	BMJ - General Practice Edition
issue	wds:Q66881435-32A5BEEF-7408-42E8-8516-E9E105FA093E
volume	wds:Q66881435-4130CBC2-E55D-43D6-98C9-460593C03729
issue	6082
volume	2
DOI	wds:Q66881435-11CBC8C3-081A-4062-8127-B26F68731576
DOI	http://dx.doi.org/10.1136/BMJ.2.6082.293
DOI	10.1136/BMJ.2.6082.293
PMCID	wds:Q66881435-871C085D-2E66-4140-B6D2-EFC8ADDC37A5
PMCID	1630784
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q66881435
is cites work of	QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study Knowledge and attitudes of parents and professionals to neonatal BCG vaccination in light of recent UK policy changes: a questionnaire study BCG vaccination in children Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans Efficacies of BCG and vole bacillus (Mycobacterium microti) vaccines in preventing clinically apparent pulmonary tuberculosis in rabbits: a preliminary report. Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG Variation in protection by BCG: implications of and for heterologous immunity Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society Comparative genomics of the mycobacteria The success and failure of BCG - implications for a novel tuberculosis vaccine Drug treatment for tuberculosis during pregnancy: safety considerations Tuberculosis: 12. Global disease and the role of international collaboration Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254. Correlation between BCG genomics and protective efficacy Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses Reducing the activity and secretion of microbial antioxidants enhances the immunogenicity of BCG. The emergence of Beijing family genotypes of Mycobacterium tuberculosis and low-level protection by bacille Calmette-Guérin (BCG) vaccines: is there a link? Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months. Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis. TB vaccines: current status and future perspectives Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Novel human in vitro system for evaluating antimycobacterial vaccines Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs Tuberculin response two years after BCG vaccination at birth Auxotrophic vaccines for tuberculosis ESX/type VII secretion systems of mycobacteria: Insights into evolution, pathogenicity and protection. Immunity to tuberculosis from the perspective of pathogenesis Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens Human and animal infections with Mycobacterium microti, Scotland Bacterial artificial chromosome-based comparative genomic analysis identifies Mycobacterium microti as a natural ESAT-6 deletion mutant Genetic vaccination against tuberculosis. Loss of anti-mycobacterial efficacy in mice over time following vaccination with Mycobacterium bovis bacillus Calmette-Guérin Priorities for screening and treatment of latent tuberculosis infection in the United States IGRA as a predictive factor of silent pulmonary changes in individuals following exposure to tuberculosis Polyantigenic interferon-γ responses are associated with protection from TB among HIV-infected adults with childhood BCG immunization Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Vaccines for tuberculosis: novel concepts and recent progress Progress in the development of vaccines and diagnostic reagents to control tuberculosis in cattle. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice BCG vaccination in the first year of life protects children of Indian subcontinent ethnic origin against tuberculosis in England

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software